Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alinity s Anti-HCV II - Clinical Evaluation Protocol

NCT04862065 is registered in ClinicalTrials.gov with Abbott Transfusion Medicine as lead sponsor.

NCT NCT04862065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04862065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alinity s Anti-HCV II - Clinical Evaluation Protocol
Lead sponsor
Abbott Transfusion Medicine
Phase
Not applicable
Overall status
Completed
Start date
April 19, 2021
Completion date
August 5, 2021
Enrollment
16,388 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

healthy